Sawyer & Company’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $343K | Sell |
14,250
-25
| -0.2% | -$654 | 0.12% | 87 |
|
|
2026
Q1 | $401K | Sell |
14,275
-650
| -4% | -$17.3K | 0.15% | 80 |
|
|
2025
Q4 | $372K | Sell |
14,925
-3,359
| -18% | -$84.7K | 0.13% | 80 |
|
|
2025
Q3 | $443K | Buy |
18,284
+4,034
| +28% | +$99.6K | 0.17% | 77 |
|
|
2025
Q2 | $343K | Sell |
14,250
-4,308
| -23% | -$100K | 0.12% | 87 |
|
|
2025
Q1 | $470K | Sell |
18,558
-597
| -3% | -$15.6K | 0.19% | 75 |
|
|
2024
Q4 | $508K | Sell |
19,155
-414
| -2% | -$11.2K | 0.19% | 78 |
|
|
2024
Q3 | $566K | Sell |
19,569
-250
| -1% | -$7.29K | 0.21% | 79 |
|
|
2024
Q2 | $555K | Sell |
19,819
-1,005
| -5% | -$27.7K | 0.22% | 76 |
|
|
2024
Q1 | $578K | Buy |
20,824
+485
| +2% | +$13.5K | 0.23% | 76 |
|
|
2023
Q4 | $586K | Sell |
20,339
-2,248
| -10% | -$68K | 0.26% | 74 |
|
|
2023
Q3 | $749K | Hold |
22,587
| – | – | 0.35% | 68 |
|
|
2023
Q2 | $828K | Hold |
22,587
| – | – | 0.38% | 70 |
|
|
2023
Q1 | $943K | Sell |
22,587
-274
| -1% | -$11.8K | 0.51% | 61 |
|
|
2022
Q4 | $1.17M | Sell |
22,861
-1,104
| -5% | -$52.9K | 0.58% | 57 |
|
|
2022
Q3 | $1.05M | Sell |
23,965
-25
| -0.1% | -$1.22K | 0.57% | 58 |
|
|
2022
Q2 | $1.26M | Sell |
23,990
-998
| -4% | -$50.9K | 0.64% | 54 |
|
|
2022
Q1 | $1.29M | Sell |
24,988
-3,208
| -11% | -$166K | 0.58% | 58 |
|
|
2021
Q4 | $1.67M | Sell |
28,196
-205
| -0.7% | -$10.2K | 0.72% | 48 |
|
|
2021
Q3 | $1.22M | Hold |
28,401
| – | – | 0.58% | 58 |
|
|
2021
Q2 | $1.11M | Buy |
28,401
+260
| +0.9% | +$10.1K | 0.52% | 62 |
|
|
2021
Q1 | $1.02M | Buy |
28,141
+324
| +1% | +$11.5K | 0.51% | 62 |
|
|
2020
Q4 | $1.02M | Sell |
27,817
-1,239
| -4% | -$45.4K | 0.52% | 61 |
|
|
2020
Q3 | $1.01M | Sell |
29,056
-289
| -1% | -$10.1K | 0.6% | 56 |
|
|
2020
Q2 | $910K | Hold |
29,345
| – | – | 0.56% | 57 |
|
|
2020
Q1 | $909K | Buy |
29,345
+250
| +0.9% | +$8.52K | 0.73% | 45 |
|
|
2019
Q4 | $1.08M | Buy |
29,095
+4,554
| +19% | +$162K | 0.7% | 46 |
|
|
2019
Q3 | $837K | Sell |
24,541
-1,060
| -4% | -$38.5K | 0.6% | 53 |
|
|
2019
Q2 | $1.05M | Sell |
25,601
-1,054
| -4% | -$41.9K | 0.7% | 46 |
|
|
2019
Q1 | $1.07M | Sell |
26,655
-175
| -0.7% | -$7.01K | 0.7% | 47 |
|
|
2018
Q4 | $1.11M | Sell |
26,830
-3,466
| -11% | -$144K | 0.82% | 42 |
|
|
2018
Q3 | $1.27M | Sell |
30,296
-761
| -2% | -$29.3K | 0.77% | 47 |
|
|
2018
Q2 | $1.07M | Hold |
31,057
| – | – | 0.7% | 51 |
|
|
2018
Q1 | $1.05M | Sell |
31,057
-317
| -1% | -$10.9K | 0.71% | 53 |
|
|
2017
Q4 | $1.08M | Buy |
+31,374
| New | +$1.07M | 0.71% | 51 |
|
Other funds holding PFE
AIM
SLAM
CWP
Sawyer & Company's PFE Position: Q2 2026 in Review
Sawyer & Company reduced its Pfizer (PFE) stake by 0.18% in Q2 2026, selling an estimated $654 and leaving 14,250 shares worth $343K. The position accounts for 0.12% of the portfolio, ranked #87.
Sawyer & Company first reported a position in PFE in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.67M in Q4 2021. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Sawyer & Company held 14,250 shares of Pfizer worth $343K as of Q2 2026.
- Sawyer & Company sold 25 Pfizer shares in Q2 2026, an estimated $654.
- Pfizer made up 0.12% of Sawyer & Company's portfolio in Q2 2026, its #87 holding.
- Sawyer & Company first reported a position in Pfizer in Q4 2017 and has held it in 35 quarters since.
- Sawyer & Company's Pfizer position peaked at $1.67M in Q4 2021.
- 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Sawyer & Company's 13F filing for Q2 2026, filed 23 Jul 2026.